HLA-DR4
From Wikipedia, the free encyclopedia
human major histocompatibility complex, class II, DR4
|
|
Haplotypes groups | DRA*01:DRB1*0401 to DRA*01:DRB1*0413 |
Structure (See HLA-DR) | |
Identifiers |
alpha *0101
|
Symbol(s) | HLA-DRA |
EBI-HLA | DRA*0101 |
Identifiers |
beta 1 *0401 to *0413
|
Symbol(s) | HLA-DRB1 |
EBI-HLA | DRB1*0401 |
EBI-HLA | DRB1*0402 |
EBI-HLA | DRB1*0403 |
EBI-HLA | DRB1*0404 |
EBI-HLA | DRB1*0405 |
EBI-HLA | DRB1*0406 |
EBI-HLA | DRB1*0407 |
EBI-HLA | DRB1*0408 |
EBI-HLA | DRB1*0409 |
EBI-HLA | DRB1*0410 |
EBI-HLA | DRB1*0411 |
EBI-HLA | DRB1*0412 |
EBI-HLA | DRB1*0413 |
Shared data | |
Locus | chr.6 6p21.31 |
HLA-DR4 (DR4) is a HLA-DR serotype that recognizes the DRB1*04 gene products. The DR4 serogroup is large and has a number of moderate frequency alleles spread over large regions of the world.
Contents |
[edit] Serology
DRB1* | DR4 | Sample |
allele | % | size (N) |
0401 | 98 | 5118 |
0402 | 92 | 1029 |
0403 | 92 | 748 |
0404 | 89 | 2164 |
0405 | 91 | 505 |
0406 | 89 | 83 |
0407 | 86 | 846 |
0408 | 86 | 258 |
0409 | 95 | 13 |
0410 | 84 | 29 |
0411 | 93 | 76 |
0412 | >50 | 1 |
0413 | >30 | 3 |
The serological identification of DR4 is good. The serology of DRB1*0417 to *0460 is unknown.
[edit] Disease associations
[edit] By serotype
DR4 is associated extraarticular[2]rheumatoid arthritis[3], hydralazine-induced female systemic lupus erythematosus[4],pemphigoid gestationis[5], phemphigus foliaceus[6], obstructive hypertrophic cardiomyopathy[7], IgA nephropathy[8] and 'shared syndrome'-systemic sclerosis/rheumatoid arthritis.[9]
[edit] By allele
DRB1*04 is associated with increased risk for alopecia areata.[10]
DRB1*0401 is associated with multiple sclerosis[11], rheumatoid arthritis[12], type 1 diabetes[13][14], lyme disease induced arthritis[15]
DRB1*0402: drug-triggered[16]/idiopathic pemphigus vulgaris[17][18], type 1 diabetes[19], SLE associated anti-cardiolipin and anti-β2 glycoprotein I[20]
DRB1*0403: polycystic ovary syndrome[21], SLE associated anti-cardiolipin and anti-β2 glycoprotein I[22]
DRB1*0404: anti-citrullinated fibrinogen[23] in rheumatoid arthritis[24], autoimmune hepatitis[25]
DRB1*0405: rheumatoid arthritis[26], Autoimmune hepatitis[27], type 1 diabetes[28][29]
DRB1*0406: caspase-8 autoantibodies silicosis-systemic sclerosis (SSc)-systemic lupus erythematosus (SLE)[30]
DRB1*0409: T. cruzi infection with cardiomyopathy[31]
[edit] By haplotype
DR4-DQ8 is a risk factor for papillary thyroid carcinoma.[32]
DRB1*04:DQA1*0303-DQB1*0401 haplotype: type III autoimmune polyglandular syndrome[33], autoimmune hepatitis [34], autoimmune pancreatitis[35]
DRB1*04:DQA1*03-DQB1*0302 haplotype: Type 1 diabetes[36][37] with DRB1*0401, *0405, *0402 increasing risk when DQ8 is present.[38]
[edit] By genotype
DRB1*0101/*0404 and *0101/*0401 increases risk of mortality in rheumatoid arthritis, with eschemic heart disease and smoking.[39] these same genotypes are associated with rheumatoid vasculitis.[40]
[edit] By haplotype
HLA DR4-DQ8 juvenile diabetes, coeliac disease, rheumatoid arthritis[41]
DRB1*04 allele group 68 Alleles: 60 proteins DR4 Serotype: *0401 to *0416 Serotype unknown: *0417 to *460
[edit] Genetic Linkage
DR4 Haplotypes
|
||||
Serotypes | DRA | DRB1 | DRB4 | |
---|---|---|---|---|
DR4-DR53 | *0101 | *0401 | *0103 | |
*0101 | *0402 | *01 | ||
*0101 | *0403 | *01 | ||
*0101 | *0404 | *01 | ||
*0101 | *0405 | *01 | ||
Serotypes | DQA1 | DQB1 | DRB1 | |
DR4-DQ7 (7.3, 3) | *0303 | *0301 | *0401 | |
DR4-DQ7 (8.1, 3) | *0301 | *0302 | *0401 | |
*0301 | *0302 | *0402 | ||
*0301 | *0302 | *0404 | ||
DR4-DQ4 (4.3) | *0303 | *0401 | *0405 | |
Serotypes | HLA-A | HLA-C | HLA-B | DRB1 |
A2-Cw10-B62(15)-DR4 | *0201 | *0304 | *1501 | *0401 |
A2-Cw10-B60(40)-DR4 | *0201 | *0304 | *4001 | *0402 |
A2-Cw5-B44(16)-DR4 | *0201 | *0501 | *4402 | *0401 |
[edit] References
- ^ derived from IMGT/HLA
- ^ Roudier J (2006). "HLA-DRB1 genes and extraarticular rheumatoid arthritis.". Arthritis Res Ther 8 (1): 103. doi: . PMID 16542468.
- ^ Winchester R (1981). "Genetic aspects of rheumatoid arthritis.". Springer Semin Immunopathol 4 (2): 89–102. doi: . PMID 6459655.
- ^ Batchelor J, Welsh K, Tinoco R, Dollery C, Hughes G, Bernstein R, Ryan P, Naish P, Aber G, Bing R, Russell G (1980). "Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.". Lancet 1 (8178): 1107–9. doi: . PMID 6103441.
- ^ Shornick J, Jenkins R, Artlett C, Briggs D, Welsh K, Kelly S, Garvey M, Black M (1995). "Class II MHC typing in pemphigoid gestationis.". Clin Exp Dermatol 20 (2): 123–6. doi: . PMID 8565245.
- ^ Matsuyama M, Hashimoto K, Yamasaki Y, Shirakura R, Higuchi R, Miyajima T, Amemiya H (1981). "HLA-DR antigens in pemphigus among Japanese.". Tissue Antigens 17 (2): 238–9. PMID 7233418.
- ^ Sakurami T, Ueno Y, Iwaki Y, Park M, Terasaki P, Saji H (1982). "HLA-DR specificities among Japanese with several autoimmune diseases.". Tissue Antigens 19 (2): 129–33. PMID 6954729.
- ^ Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyajima T (1982). "Strong association between IgA nephropathy and HLA-DR4 antigen.". Kidney Int 22 (4): 377–82. doi: . PMID 6217371.
- ^ Szücs G, Szekanecz Z, Zilahi E, et al (2007). "Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity". Rheumatology (Oxford, England) 46 (6): 989–93. doi: . PMID 17384178.
- ^ Entz P, Blaumeiser B, Betz RC, et al (2006). "Investigation of the HLA-DRB1 locus in alopecia areata". European journal of dermatology : EJD 16 (4): 363–7. PMID 16935791.
- ^ Laroni A, Calabrese M, Perini P, Albergoni M, Ranzato F, Tiberio M, Battistin L, Gallo P (2006). "Multiple sclerosis and autoimmune diseases : Epidemiology and HLA-DR association in North-east Italy.". J Neurol 253 (5): 636–9. doi: . PMID 16502215.
- ^ Angelini G, Morozzi G, Delfino L, Pera C, Falco M, Marcolongo R, Giannelli S, Ratti G, Ricci S, Fanetti G (1992). "Analysis of HLA DP, DQ, and DR alleles in adult Italian rheumatoid arthritis patients.". Hum Immunol 34 (2): 135–41. doi: . PMID 1429034.
- ^ Fernandez-Viña M, Ramirez L, Raskin P, Stastny P (1993). "Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans.". Tissue Antigens 41 (2): 57–64. PMID 8475491.
- ^ Undlien D, Friede T, Rammensee H, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen H, Knutsen I, Rønningen K, Thorsby E (1997). "HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.". Diabetes 46 (1): 143–9. doi: . PMID 8971095.
- ^ Gross D, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy Z, Field J, Steere A, Huber B (1998). "Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.". Science 281 (5377): 703–6. doi: . PMID 9685265.
- ^ Matzner Y, Erlich H, Brautbar C, Sanilevitch A, Landau M, Brenner S, Friedmann A (1995). "Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris.". Acta Derm Venereol 75 (1): 12–4. PMID 7747528.
- ^ Sáenz-Cantele AM, Fernández-Mestre M, Montagnani S, Calebotta A, Balbas O, Layrisse Z (2007). "HLA-DRB1*0402 haplotypes without DQB1*0302 in Venezuelan patients with pemphigus vulgaris". Tissue Antigens 69 (4): 318–325. doi: . PMID 17389015.
- ^ Lee E, Lendas K, Chow S, Pirani Y, Gordon D, Dionisio R, Nguyen D, Spizuoco A, Fotino M, Zhang Y, Sinha A. "Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris.". Hum Immunol 67 (1-2): 125–39. doi: . PMID 16698434.
- ^ Undlien D, Friede T, Rammensee H, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen H, Knutsen I, Rønningen K, Thorsby E (1997). "HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.". Diabetes 46 (1): 143–9. doi: . PMID 8971095.
- ^ Galeazzi M, Sebastiani G, Tincani A, Piette J, Allegri F, Morozzi G, Bellisai F, Scorza R, Ferrara G, Carcassi C, Font J, Passiu G, Smolen J, Papasteriades C, Houssiau F, Nebro A, Ramon Garrido E, Jedryka-Goral A, Marcolongo R (2000). "HLA class II alleles associations of anticardiolipin antibodies". Lupus 9 (1): 47–55. PMID 10715100.
- ^ Kaibe M, Takakuwa K, Murakawa H, Ishii K, Tamura M, Tanaka K (2006). "Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population--possible susceptibility of HLA-A11 and -DRB1*0403 to patient population with polycystic ovary syndrome.". Am J Reprod Immunol 55 (4): 301–6. doi: . PMID 16533342.
- ^ Galeazzi M, Sebastiani G, Tincani A, Piette J, Allegri F, Morozzi G, Bellisai F, Scorza R, Ferrara G, Carcassi C, Font J, Passiu G, Smolen J, Papasteriades C, Houssiau F, Nebro A, Ramon Garrido E, Jedryka-Goral A, Marcolongo R (2000). "HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.". Lupus 9 (1): 47–55. doi: . PMID 10715100.
- ^ Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J (2005). "Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.". Arthritis Rheum 52 (11): 3424–32. doi: . PMID 16255019.
- ^ Angelini G, Morozzi G, Delfino L, Pera C, Falco M, Marcolongo R, Giannelli S, Ratti G, Ricci S, Fanetti G (1992). "Analysis of HLA DP, DQ, and DR alleles in adult Italian rheumatoid arthritis patients.". Hum Immunol 34 (2): 135–41. doi: . PMID 1429034.
- ^ Vázquez-García M, Aláez C, Olivo A, Debaz H, Pérez-Luque E, Burguete A, Cano S, de la Rosa G, Bautista N, Hernández A, Bandera J, Torres L, Kershenobich D, Alvarez F, Gorodezky C (1998). "MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis.". J Hepatol 28 (6): 985–90. doi: . PMID 9672174.
- ^ Al-Swailem R, Al-Rayes H, Sobki S, Arfin M, Tariq M (2006). "HLA-DRB1 association in Saudi rheumatoid arthritis patients.". Rheumatol Int 26 (11): 1019–24. doi: . PMID 16673133.
- ^ Ota M, Seki T, Kiyosawa K, Furuta S, Hino K, Kondo T, Fukushima H, Tsuji K, Inoko H (1992). "A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis.". Immunogenetics 36 (1): 49–55. doi: . PMID 1350267.
- ^ Fernandez-Viña M, Ramirez L, Raskin P, Stastny P (1993). "Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans.". Tissue Antigens 41 (2): 57–64. PMID 8475491.
- ^ Undlien D, Friede T, Rammensee H, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen H, Knutsen I, Rønningen K, Thorsby E (1997). "HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.". Diabetes 46 (1): 143–9. doi: . PMID 8971095.
- ^ Ueki A, Isozaki Y, Kusaka M (2005). "Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles.". J Occup Health 47 (1): 61–7. doi: . PMID 15703453.
- ^ García Borrás S, Diez C, Cotorruelo C, et al (2006). "HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection". Ann. Clin. Biochem. 43 (Pt 3): 214–6. doi: . PMID 16704757.
- ^ Porto T, Coelho I, Boavida J, et al (2006). "Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas". Clin. Endocrinol. (Oxf) 64 (2): 179–83. doi: . PMID 16430717.
- ^ Hashimoto K, Maruyama H, Nishiyama M, Asaba K, Ikeda Y, Takao T, Iwasaki Y, Kumon Y, Suehiro T, Tanimoto N, Mizobuchi M, Nakamura T (2005). "Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.". Horm Res 64 (5): 253–60. doi: . PMID 16254435.
- ^ Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K (2005). "Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis.". J Hepatol 42 (4): 578–84. doi: . PMID 15763345.
- ^ Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K (2002). "HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population.". Gastroenterology 122 (5): 1264–9. doi: . PMID 11984513.
- ^ Park Y, Tait B, Kawasaki E, Rowley M, Mackay I. "Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients.". Ann N Y Acad Sci 1037: 104–9. doi: . PMID 15699500.
- ^ Hermann R, Turpeinen H, Laine A, Veijola R, Knip M, Simell O, Sipilä I, Akerblom H, Ilonen J (2003). "HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families.". Tissue Antigens 62 (2): 162–9. doi: . PMID 12889996.
- ^ Thomson G, Valdes AM, Noble JA, et al (2007). "Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis". Tissue Antigens 70 (2): 110–27. doi: . PMID 17610416.
- ^ Mattey DL, Thomson W, Ollier WE, et al (2007). "Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study". Arthritis Rheum. 56 (5): 1408–16. doi: . PMID 17469097.
- ^ Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA (2004). "Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis". Arthritis Rheum. 50 (11): 3476–84. doi: . PMID 15529352.
- ^ Singal D, Green D, Reid B, Gladman D, Buchanan W (1992). "HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.". Ann Rheum Dis 51 (1): 23–8. PMID 1371662.
|